Drugs / Qiqi Shengmai Decoction
Qiqi Shengmai Decoction
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07286110 | Dec 2025 → Nov 2026 expected | Moyamoya disease | Fudan University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qiqi Shengmai Decoction | “Patients receive the standardized TCM formula Qiqi Shengmai Decoction (composed of Astragali Radix, Rehmanniae Radix Praeparata, Schisandrae Fructus, Bupleuri Radix, Paeoniae...” NCT07286110 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “standardized TCM formula Qiqi Shengmai Decoction” NCT07286110 ↗ |
| Route | Oral | “with each dose consumed 30 minutes after breakfast and dinner” NCT07286110 ↗ |